| 811 |
Prospective Clinical Trial of Dapson in Resistant Patients of Chronic ITP Refusing Splenectomy. |
2003 |
| 812 |
Prospective Clinical Trial of Dapsone in Resistant Patients of Chronic ITP Refusing Splenectomy. |
2003 |
| 813 |
Prospective Clinical Trial of Dapsone in Resistant Patients with Chronic ITP Refusing Splenectomy |
2003 |
| 814 |
Role of plasmapheresis and cytokines (IL-1β, TNF-α and IL-6) in active rheumatoid arthritis. |
2003 |
| 815 |
Role of plasmaphersis and cytokines (IL-1beta,TNF alpha and IL-6)in active rheumatoid arthritis |
2003 |
| 816 |
Role of plasmaphersis and cytokines (IL-1beta,TNF alpha and IL-6)in active rheumatoid arthritis |
2003 |
| 817 |
SERUM CARBOHYDRATE ANTIGEN-125 LEVELS AS A marker in non Hodgkin’s lymphoma |
2003 |
| 818 |
Serum levels of Glutamic Acid Decarboxylase autoantibodies (GADA), Soluble Fas/Apo-1 (CD 95), IL-1 and No in children with insulin- dependent DM |
2003 |
| 819 |
Serum levels of Glutamic Acid Decarboxylase autoantibodies (GADA), Soluble Fas/Apo-1 (CD 95), IL-1 and No in children with insulin- dependent DM |
2003 |
| 820 |
Serum soluble interleukin -2 receptor levels as a biochemical marker for T-cell mediated graft rejection in renal transplantation and acute graft-versus-host diseases in peripheral blood stem cell transplantation |
2003 |
هل لديك سؤال ؟
